
Upon completion of this CME activity, the participant should be able to:
This lecture reviews the issues involved in the evaluation and treatment of early failure in antiretroviral experienced patients. Join Dr. Paul Sax as he reviews recent changes in the DHHS Guidelines (January, 2008) and data from the 15th CROI as well as topics including resistance, and the use of current and new classes of agents in this patient population.
CME Credit Information
| Release Date: | February 26, 2008 |
| Expiration Date: | February 26, 2009 |
| Physicians: | maximum of 1.0 AMA PRA category 1 Credit(s)™ |
This lecture discusses the clinical management of antiretroviral treatment experienced patients in late failure. Join Dr. Cal Cohen as he reviews the most recent data in this complex patient population, including the most recent data from the 15th CROI on the use of new antiretrovirals such as etravirine, maraviroc and raltegravir.
CME Credit Information
| Release Date: | February 26, 2008 |
| Expiration Date: | February 26, 2009 |
| Physicians: | maximum of 1.0 AMA PRA category 1 Credit(s)™ |
This lecture discusses the clinical management of antiretroviral treatment experienced patients in all stages offailure. Join Dr. Ian Frank as he reviews the most recent data in this complex patient population, by reviewing patient cases in early and late failure as well as salvage. Recent changes in the DHHS guidelines (December 2007) will be reviewed as well as topics such as resistance.
CME Credit Information
| Release Date: | January 30, 2008 |
| Expiration Date: | January 29, 2009 |
| Physicians: | maximum of 1.0 AMA PRA category 1 Credit(s)™ |

